Sleep Medicine
News from the FDA/CDC
FDA approves Dayvigo for insomnia
The orexin receptor antagonist will be available in 5-mg and 10-mg tablets after DEA scheduling.
News
Novel analysis links insomnia to first-onset major depressive disorder
First-onset major depressive disorder was significantly associated with difficulty initiating sleep among individuals in a 6-year prospective...
News
Heart rate changes during sleep may be diagnostic tool for depression
A heart rate–profiling algorithm shows promise at distinguishing differences in heart rate patterns during sleep between people with depression...
Article
Treatment of OSA: What (else) can it accomplish?
Treatment of obstructive sleep apnea improves daytime sleepiness, but does it improve other outcomes?
Conference Coverage
Helping adolescents get enough quality sleep
NEW ORLEANS – Everything from social activities to school demands to technology can interfere with teens’ ability to get enough quantity and...
Conference Coverage
Disentangling sleep problems and bipolar disorder
COPENHAGEN – “Anybody who deals with bipolar patients knows that sleep is a constant issue.”
Conference Coverage
Reappraising standard treatment of comorbid insomnia/depression
COPENHAGEN – “There are some effects on insomnia when you treat depression, but they’re not very large.”
News
Veterans at higher risk of sleep behavior disorders
Veterans with a history of PTSD or traumatic brain injury may be at higher risk of REM sleep behavior disorders.
News
Mandatory OSA treatment for truckers lowers insurance costs
Treated truckers saw health care savings that could help offset the costs of OSA programs.
Literature Review
Insomnia symptoms increase likelihood of stroke and heart disease
A positive dose-response relationship exists between the number of insomnia symptoms and the risk of cardiocerebral vascular disease, according to...